Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA.
Pediatr Res. 2017 Apr 18;:
Authors: Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N
Abstract BACKGROUND: Neuroblastoma is the second most common extracranial cancer in children.